IRIS
AMPOLLINI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.328
NA - Nord America 6.392
AS - Asia 3.180
SA - Sud America 172
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 19.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.336
IT - Italia 5.134
CN - Cina 1.758
IE - Irlanda 1.063
SG - Singapore 959
SE - Svezia 794
FI - Finlandia 726
FR - Francia 391
DE - Germania 363
TR - Turchia 275
UA - Ucraina 258
GB - Regno Unito 151
BR - Brasile 143
NL - Olanda 99
IN - India 74
AT - Austria 69
RU - Federazione Russa 62
BE - Belgio 54
CA - Canada 49
CH - Svizzera 36
CZ - Repubblica Ceca 31
BD - Bangladesh 21
CI - Costa d'Avorio 19
ES - Italia 17
DK - Danimarca 13
HK - Hong Kong 13
IR - Iran 13
LT - Lituania 11
AR - Argentina 10
RO - Romania 10
ID - Indonesia 9
PL - Polonia 8
PK - Pakistan 7
IL - Israele 6
CL - Cile 5
CO - Colombia 5
EU - Europa 5
MA - Marocco 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
GR - Grecia 4
JO - Giordania 4
JP - Giappone 4
LK - Sri Lanka 4
LU - Lussemburgo 4
PH - Filippine 4
PT - Portogallo 4
SI - Slovenia 4
TW - Taiwan 4
UZ - Uzbekistan 4
VE - Venezuela 4
EC - Ecuador 3
EG - Egitto 3
KZ - Kazakistan 3
MX - Messico 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KR - Corea 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
CR - Costa Rica 1
HN - Honduras 1
IQ - Iraq 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
SM - San Marino 1
TN - Tunisia 1
UY - Uruguay 1
VN - Vietnam 1
Totale 19.116
Salva come PNG Salva come JPEG
Città #
Chandler 1.199
Dublin 1.061
Singapore 678
Santa Clara 528
Beijing 454
Ashburn 378
Ann Arbor 351
Dearborn 324
Milan 320
Boardman 301
Parma 275
Rome 275
Izmir 253
Nanjing 249
Jacksonville 207
Princeton 205
New York 189
Shanghai 167
Wilmington 120
Helsinki 95
San Mateo 95
Jinan 88
Bologna 86
Shenyang 78
Kunming 76
Seattle 76
Bremen 75
Chicago 72
Nanchang 66
Naples 63
Turin 60
Hebei 58
Hefei 54
Vienna 54
Los Angeles 52
Brussels 51
Guangzhou 49
Des Moines 46
Moscow 45
Jiaxing 44
Florence 43
Catania 41
Padova 41
Rio Saliceto 40
Napoli 39
Palermo 38
Changsha 34
Genoa 34
Tianjin 33
Fremont 31
Toronto 31
Genova 29
Houston 28
Bari 27
Woodbridge 27
Munich 26
Brescia 25
Norwalk 25
Perugia 25
London 24
Düsseldorf 22
Zhengzhou 21
Torino 20
Abidjan 19
Frankfurt am Main 19
Nuremberg 19
Pisa 19
Modena 18
Reggio Emilia 18
Augusta 17
Chengdu 17
Dallas 16
Hangzhou 16
Council Bluffs 15
Monza 15
Paris 14
Pescara 14
Crema 13
Haikou 13
Pune 13
Brno 12
Falls Church 12
Fuzhou 12
Kocaeli 12
Livorno 12
Monmouth Junction 12
Redwood City 12
Salerno 12
Amsterdam 11
Leawood 11
Ningbo 11
Trieste 11
Verona 11
Bergamo 10
Ferrara 10
Ottawa 10
Siena 10
Taizhou 10
Desio 9
Fairfield 9
Totale 10.115
Salva come PNG Salva come JPEG
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.186
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.609
Aerostasi in chirurgia toracica nell’Azienda Ospedaliero-Universitaria di Parma: introduzione nella pratica clinica del Tachosil, un sigillante registrato come farmaco 926
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 310
Diverticolo tracheale acquisito: una rara causa di emottisi 292
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 207
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 157
Fistola tracheo-esofagea congenita di tipo “H” nell’adulto 155
A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity 149
Leiomioma metastatizzante benigno gigante 134
Hydrogen sulfide inhibits tmprss2 in human airway epithelial cells: Implications for sars‐cov‐2 infection 131
Adenocarcinoma associato a melanoma amelanotico primario dell’esofago distale 129
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 128
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 123
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 123
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 122
Lipoma endobronchiale: una rara causa di ostruzione bronchiale 113
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 110
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 110
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 108
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 107
Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study 106
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 106
Intraoperative Endobronchial swab after major lung resection: does it influence the course of postoperative pulmonary infections ? 104
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 103
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 102
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 101
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 99
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 99
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 99
Isolation and characterization of human lung lymphatic endothelial cells 98
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 95
Lung metastasis resection of adenoid cystic carcinoma of salivary glands 94
Physico-chemical characterization and biological evaluation of two fibroin materials 94
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 93
Antitumoral effect of a nanotechnology-based photodynamic therapy. 93
Linezolid-induced black hairy tongue 92
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 91
Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry 90
Neoplasie del polmone in Neoplasie del Distretto Toracico 89
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 89
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 88
IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma 88
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 86
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer 85
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 85
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 85
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 84
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 84
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 84
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 83
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) 83
Cardiac autonomic and cortisol stress responses to real operations in surgeons: relationship with individual psychobiological characteristics and experience 82
A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery 82
A huge ulcerated mass of the thorax 82
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 82
Cardiac tanponade in patient vith thoraco-abdominal aortic aneurysm 81
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 81
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 80
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 79
Cavernous hemangioma of the posterior mediastinum 79
Unusual case of giant typical carcinoid tumor 78
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 78
Posterior mediastinal myelolipoma resected by video-assisted thoracic surgery 78
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 78
Intrapleural application of polymeric films containing cisplatin and pemetrexed in a rat tumour model of malignant pleural mesothelioma 77
Multiple primary malignancies involving lung cancer: a single-center experience 77
The value of lung metastases resection from adenoid cystic carcinoma 76
Resection of giant typical carcinoid tumor with cardiopulmonary bypass support. 76
Insolita evoluzione della cavità pleurica dopo pneumonectomia destra 73
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 73
Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) 73
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids 73
An unusual case of thoracic calcifyng fibrous pseudotumor 73
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 72
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 72
Abdominal visceral hernia through a chest wall defect secondary to open-window thoracostomy 72
Transcervical video-assisted thymectomy:preliminary results of a modified surgical approach 71
Long-lasting tuberculous pleurisy 71
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 71
Successful esophageal repair in patient with Boerhaave's sindrome. 71
Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax. 71
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 71
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 70
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 70
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 70
Incidenza e trattamento delle recidive dopo intervento chirurgico 69
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 69
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 69
DIAPHRAGMATIC LACERATION PARTIAL LIVER HERNIATION AND CATAMENIAL PNEUMOTHORAX 69
Exercise capacity assessment in patients undergoing lung resection 69
A novel method of tracheoesophageal fistula closure 68
Metastasectomia polmonare secondaria a tumore renale (RCC). Esperienza di Parma 68
Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on ct: Relation to clinical metrics 68
Prophylactic Use of Helmet-CPAP After Pulmonary Lobectomy: A Prospective Randomized Controlled Study. 67
Postoperative Subconjunctival Emphysema 67
Ground glass nodules evolution according with an history of tumour 67
Placental Transmogrification of the Lung Presenting as a Giant Bulla Associated with a Pulmonary Hamartoma 67
227P Sexual dimorphism in immune profile of early and advanced NSCLC 66
Three different synchronous unilateral lung cancers: a case report 65
Totale 13.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020587 0 0 0 0 0 0 0 0 202 183 91 111
2020/20211.660 58 110 97 126 207 126 142 104 229 103 253 105
2021/20221.436 85 72 92 104 51 60 158 132 91 114 63 414
2022/20234.819 422 518 282 366 375 554 142 351 1.367 70 264 108
2023/20242.534 179 223 101 94 198 471 195 195 148 175 195 360
2024/20253.173 177 344 400 302 579 554 274 249 294 0 0 0
Totale 19.448